InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: surf1944 post# 445

Thursday, 10/15/2009 7:01:55 AM

Thursday, October 15, 2009 7:01:55 AM

Post# of 3991

Protalix reports positive Phase III trial results

Oct. 15, 2009, 6:15 a.m. EDT LONDON (MarketWatch) -- Protalix BioTherapeutics on Thursday reported positive top-line results from its Phase III clinical trial of UPLYSO in treatment naive patients diagnosed with Gaucher disease. The company said the trial met its primary endpoint, mean reduction in spleen volume after nine months compared with baselines, at two different dosage levels. Statistically significant improvements compared with baselines were also observed in the secondary endpoints. The company said it plans to present more comprehensive results in the near future.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News